đź“Ť Mobile Treatment Unit's current location:

Predicting Treatment Adherence in Opioid Use Disorder

Schedule An Appointment

MATClinics Unveils Pioneering Study on Predicting Treatment Adherence in Opioid Use Disorder

By Dan Reck, CEO, MATClinics News
August 2022

‍

A New Era in Predictive Care for Addiction

In the fight against opioid addiction, ensuring patients adhere to medication can be a significant challenge. MATClinics aims to change this narrative with innovative research that bridges clinical practice and data-driven insights.

Our peer-reviewed study, titled “Using Machine Learning to Predict Treatment Adherence in Patients on Medication for Opioid Use Disorder,” explores the use of advanced machine learning techniques to predict treatment adherence and opioid abstinence. The research, conducted by a team of experts including Albert J. Burgess-Hull, Enrique Oviedo, and others, leverages data from over 2,700 patients across multiple outpatient locations.

Key Insights from the Study

This comprehensive analysis utilized urine drug screens and attendance records from a staggering 40,005 appointments. By applying machine learning algorithms—specifically logistic regression and XGBoost—we sought to identify patterns that could help predict which patients are likely to adhere to their medication regimen.

Significant Findings:

  1. Accuracy in Prediction: The XGBoost model demonstrated comparable accuracy to traditional logistic regression models, achieving an accuracy rate of 88% and an area under the receiver operating characteristic curve (AUROC) of 0.87.
  2. Factors Influencing Adherence: Key predictors included historical treatment adherence, attendance rates, and current urine tests for fentanyl, underscoring the complexity of medication adherence and the need for tailored interventions.

Why This Research Matters

The ability to predict treatment adherence is crucial, especially given that 50-80% of patients may continue to struggle with substance use during treatment. Early identification of those at high risk for non-adherence can enhance clinical decision-making and improve patient outcomes.

Integrating Research into Practice

This study is not just an academic exercise; it’s a vital part of our mission at MATClinics. By marrying clinical care with research, we can adapt our approaches in real-time and enhance treatment pathways. Here are actionable steps derived from our findings:

  1. Customize Treatment Plans: Use patient-specific data to tailor when and how injectable medications are introduced.
  2. Enhance Patient Support: Implement regular check-ins and tailored support for patients identified as at-risk for non-adherence.
  3. Monitor and Adapt: Continuously assess the effectiveness of predictive models and be open to integrating new data points as they emerge.

Looking Ahead

As we continue to refine our methodologies, we are also expanding our research partnerships and introducing innovative solutions like mobile treatment units to extend our reach to underserved communities.

Conclusion

At MATClinics, we believe that integrating research into treatment is essential for improving patient outcomes in opioid use disorder. By utilizing predictive analytics, we can empower patients and providers alike to make informed decisions that foster long-term recovery.

‍